Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.22 USD | +0.77% | +6.31% | +1.56% |
Valuation
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Capitalization 1 | 9.857 | 19.33 | 62.4 | 48.31 | 68.45 | 68.98 | - | - |
Enterprise Value (EV) 1 | 9.857 | 19.33 | 62.4 | 48.31 | 68.45 | 68.98 | 68.98 | 68.98 |
P/E ratio | -1.15 x | -1.15 x | -3.47 x | -2.32 x | -2.69 x | -3.7 x | -7.73 x | 16.7 x |
Yield | - | - | - | - | - | - | - | - |
Capitalization / Revenue | 316 x | - | - | - | - | - | 2.84 x | 1.22 x |
EV / Revenue | 316 x | - | - | - | - | - | 2.84 x | 1.22 x |
EV / EBITDA | - | - | - | - | - | - | - | - |
EV / FCF | - | - | - | - | - | - | - | - |
FCF Yield | - | - | - | - | - | - | - | - |
Price to Book | - | - | - | - | - | - | - | - |
Nbr of stocks (in thousands) | 717 | 2,234 | 9,468 | 9,472 | 13,317 | 13,317 | - | - |
Reference price 2 | 13.75 | 8.650 | 6.590 | 5.100 | 5.140 | 5.180 | 5.180 | 5.180 |
Announcement Date | 3/18/20 | 3/31/21 | 3/28/22 | 3/2/23 | 2/29/24 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net sales 1 | 0.0312 | - | - | - | - | - | 24.32 | 56.68 |
EBITDA | - | - | - | - | - | - | - | - |
EBIT 1 | -7.675 | -9.135 | -16.89 | -24.93 | -25.24 | -25.84 | -14.82 | 8.87 |
Operating Margin | -24,568.85% | - | - | - | - | - | -60.94% | 15.65% |
Earnings before Tax (EBT) | -7.625 | - | - | - | - | - | - | - |
Net income 1 | -7.625 | -9.743 | -16.53 | -24.67 | -23.52 | -26.08 | -15.06 | 8.64 |
Net margin | -24,409.09% | - | - | - | - | - | -61.92% | 15.24% |
EPS 2 | -12.00 | -7.540 | -1.900 | -2.200 | -1.910 | -1.400 | -0.6700 | 0.3100 |
Free Cash Flow | - | - | - | - | - | - | - | - |
FCF margin | - | - | - | - | - | - | - | - |
FCF Conversion (EBITDA) | - | - | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - | - | - |
Announcement Date | 3/18/20 | 3/31/21 | 3/28/22 | 3/2/23 | 2/29/24 | - | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales 1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.6 |
EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBIT 1 | -2.707 | -8.992 | -5.335 | -6.986 | -6.151 | -6.46 | -6.797 | -6.814 | -5.349 | -6.278 | -6.6 | -6.64 | -5.94 | -6.65 | -6.89 |
Operating Margin | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -1,148.33% |
Earnings before Tax (EBT) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net income 1 | -2.4 | -8.988 | -5.33 | -7.062 | -6.097 | -6.18 | -6.392 | -6.474 | -5.001 | -5.649 | -6.66 | -6.7 | -6 | -6.71 | -6.95 |
Net margin | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -1,158.33% |
EPS 2 | -0.2600 | -0.9400 | -0.4700 | -0.6300 | -0.5400 | -0.5500 | -0.5700 | -0.5800 | -0.4500 | -0.3200 | -0.4000 | -0.3600 | -0.3100 | -0.3400 | -0.3300 |
Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Announcement Date | 11/11/21 | 3/28/22 | 4/29/22 | 8/3/22 | 10/27/22 | 3/2/23 | 4/28/23 | 7/31/23 | 10/26/23 | 2/29/24 | - | - | - | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net Debt | - | - | - | - | - | - | - | - |
Net Cash position | - | - | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
Free Cash Flow | - | - | - | - | - | - | - | - |
ROE (net income / shareholders' equity) | - | - | - | - | - | - | - | - |
ROA (Net income/ Total Assets) | - | - | - | - | - | - | - | - |
Assets 1 | - | - | - | - | - | - | - | - |
Book Value Per Share | - | - | - | - | - | - | - | - |
Cash Flow per Share | - | - | - | - | - | - | - | - |
Capex 1 | - | 0.18 | - | 0.12 | 0.03 | 0.2 | 0.1 | 0.1 |
Capex / Sales | - | - | - | - | - | - | 0.41% | 0.18% |
Announcement Date | 3/18/20 | 3/31/21 | 3/28/22 | 3/2/23 | 2/29/24 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.56% | 68.98M | |
+1.77% | 42.75B | |
+47.70% | 41.61B | |
+12.24% | 41.34B | |
-8.83% | 26.59B | |
+7.44% | 25.49B | |
-23.01% | 18.12B | |
+30.56% | 12.24B | |
-1.82% | 11.76B | |
+8.35% | 11B |
- Stock Market
- Equities
- NVNO Stock
- Financials enVVeno Medical Corporation